Horwood Jeremy, Cabral Christie, Hay Alastair D, Ingram Jenny
Centre for Academic Primary Care, NIHR School of Primary Care Research, School of Social and Community Medicine.
Centre for Child and Adolescent Health, Schoolof Social and Community Medicine, University of Bristol, Bristol.
Br J Gen Pract. 2016 Mar;66(644):e207-13. doi: 10.3399/bjgp16X683821. Epub 2016 Feb 7.
Respiratory tract infections (RTIs) are a major primary care challenge in children because they are common and costly, there is uncertainty regarding their diagnosis, prognosis, and management, and the overuse of antibiotics leads to illness medicalisation and bacterial resistance.
To investigate healthcare professional (HCP) diagnostic and antibiotic prescribing decisions for children with RTIs.
Semi-structured interviews conducted with 22 GPs and six nurses. HCPs were recruited from six general practices and one walk-in centre, serving a mix of deprived and affluent areas.
Interviews were audiorecorded, transcribed, imported into NVivo 9, and analysed thematically.
HCPs varied in the symptom and clinical examination findings used to identify children they thought might benefit from antibiotics. Their diagnostic reasoning and assessment of perceived clinical need for antibiotics used a dual process, combining an initial rapid assessment with subsequent detailed deductive reasoning. HCPs reported confidence diagnosing and managing most minor and severe RTIs. However, residual prognostic uncertainty, particularly for the intermediate illness severity group, frequently led to antibiotic prescribing to mitigate the perceived risk of subsequent illness deterioration. Some HCPs perceived a need for more paediatrics training to aid treatment decisions. The study also identified a number of non-clinical factors influencing prescribing.
Prognostic uncertainty remains an important driver of HCPs' antibiotic prescribing. Experience and training in recognising severe RTIs, together with more evidence to help HCPs identify the children at risk of future illness deterioration, may support HCPs' identification of the children most and least likely to benefit from antibiotics.
呼吸道感染(RTIs)是儿童初级医疗保健面临的一项重大挑战,因为其发病率高且成本高昂,在诊断、预后和管理方面存在不确定性,而且抗生素的过度使用会导致疾病医疗化和细菌耐药性。
调查医疗保健专业人员(HCP)对患有呼吸道感染儿童的诊断及抗生素处方决策。
对22名全科医生和6名护士进行半结构式访谈。HCPs来自六个普通诊所和一个随到随诊中心,服务于贫困和富裕混合地区。
访谈进行录音、转录,导入NVivo 9并进行主题分析。
HCPs在用于识别他们认为可能受益于抗生素的儿童的症状和临床检查结果方面存在差异。他们对抗生素的诊断推理和对感知到的临床需求的评估采用了双重过程,将初步快速评估与随后的详细演绎推理相结合。HCPs报告称对诊断和管理大多数轻度和重度RTIs有信心。然而,残留的预后不确定性,特别是对于中度疾病严重程度组,经常导致开具抗生素以降低随后疾病恶化的感知风险。一些HCPs认为需要更多的儿科培训来辅助治疗决策。该研究还确定了一些影响处方的非临床因素。
预后不确定性仍然是HCPs开具抗生素的一个重要驱动因素。识别严重RTIs的经验和培训,以及更多帮助HCPs识别未来疾病恶化风险儿童的证据,可能有助于HCPs识别最有可能和最不可能从抗生素中受益的儿童。